Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Waran Seri I ITSEC Asia Tbk. (CYBR-W) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Waran Seri I ITSEC Asia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Waran Seri I ITSEC Asia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Waran Seri I ITSEC Asia Tbk. trades at Rp376 (market cap 154.89B, 900 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 4.2× Waran Seri I ITSEC Asia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (848.2K versus 900). Which is the better fit depends on your goals.

CYBR-WLABS
Market Cap
154.89B651.75B
Volume
900848.2K
Lot
98.48K
Turnover
337K140.51M
Average Price
374.44165.66
Value
337K140.51M
Indicative Equilibrium Price
168
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details

About Waran Seri I ITSEC Asia Tbk.

PT ITSEC Asia Tbk (the “Company”) was established based on Notarial Deed No. 7 dated April 12, 2010 of Refizal, S.H., M.Hum., notary in Jakarta. The Company started its commercial operations in 2010.

Read more on CYBR-W

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS